Literature DB >> 7500053

T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells.

J E Maguire1, K M Danahey, L C Burkly, G A van Seventer.   

Abstract

The beta 1 subfamily of integrins is thought to play an important role in both the adhesion/migration and proliferation/differentiation of T cells. beta 1 integrins can provide T cell costimulation through interaction of very late antigen (VLA) 4 (VLA-4) (alpha 4 beta 1) and VLA-5 (alpha 5 beta 1) with the extracellular matrix protein fibronectin (FN), or by VLA-4 binding to its cell surface ligand, vascular cell adhesion molecule (VCAM) 1. The mechanism by which beta 1 integrin members transduce T cell-costimulatory signals is poorly understood. Studies in non-T cells have demonstrated regulation of the tyrosine focal adhesion kinase pp125FAK by beta 1 integrin engagement and, most recently, indicate a role for pp125FAK in linking integrin-mediated signal transduction to the Ras pathway (Schaller, M. D., and J. T. Parsons, 1994, Curr. Opin. Cell. Biol. 6: 705-710; Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. Van der Geer. 1994. Nature (Lond.), 372:786-790). Although pp125FAK kinase occurs in T cells, there are no reports on its regulation in this cell type. The studies described in this article characterize novel regulation of pp125FAK by the T cell receptor (TCR)-CD3 antigen complex and beta 1 integrins, and provide the first account, in any cell type, of integrin alpha 4 beta 1-mediated pp125FAK tyrosine phosphorylation. We demonstrate a rapid and sustained synergistic increase in tyrosine phosphorylation of human pp125FAK in Jurkat T cells after simultaneous (a) triggering of the TCR-CD3 complex, and (b) alpha 4 beta 1 and alpha 5 beta 1 integrin-mediated binding of these cells to immobilized FN or alpha 4 beta 1 integrin-mediated binding to immobilized VCAM-1. Studies with normal peripheral blood-derived CD4+ human T blasts confirm the synergistic action of a TCR-CD3 complex-mediated costimulus with a FN- or VCAM-1-dependent signal in the induction of T cell pp125FAK tyrosine phosphorylation. In vitro kinase assays performed on pp125FAK immunoprecipitates isolated from Jurkat cells and normal CD4+ T cells identified a coprecipitating 57-kD tyrosine-phosphorylated protein (pp57), distinct from pp59fyn or pp56lck. These results indicate, for the first time, the involvement of a specific kinase, pp125FAK, in alpha 4 beta 1- and alpha 5 beta 1-mediated T cell-costimulatory signaling pathways. In addition, the data demonstrate novel regulation of pp125FAK tyrosine phosphorylation by the TCR-CD3 complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500053      PMCID: PMC2192271          DOI: 10.1084/jem.182.6.2079

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  56 in total

1.  Focal adhesion kinase: an integrin-linked protein tyrosine kinase.

Authors:  M D Schaller; J T Parsons
Journal:  Trends Cell Biol       Date:  1993-08       Impact factor: 20.808

Review 2.  Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples.

Authors:  A Kupfer; S J Singer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

4.  Vascular cell adhesion molecule (VCAM)-Ig fusion protein defines distinct affinity states of the very late antigen-4 (VLA-4) receptor.

Authors:  A Jakubowski; M D Rosa; S Bixler; R Lobb; L C Burkly
Journal:  Cell Adhes Commun       Date:  1995-05

5.  Stimulation of tyrosine phosphorylation and accumulation of GTP-bound p21ras upon antibody-mediated alpha 2 beta 1 integrin activation in T-lymphoblastic cells.

Authors:  C Kapron-Bras; L Fitz-Gibbon; P Jeevaratnam; J Wilkins; S Dedhar
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

6.  Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin.

Authors:  S Rankin; E Rozengurt
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

7.  Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase.

Authors:  H C Chen; J L Guan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

8.  Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues.

Authors:  G E Rice; J M Munro; C Corless; M P Bevilacqua
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

9.  Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes.

Authors:  R Pulido; M J Elices; M R Campanero; L Osborn; S Schiffer; A García-Pardo; R Lobb; M E Hemler; F Sánchez-Madrid
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

10.  Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein.

Authors:  Y Nojima; D M Rothstein; K Sugita; S F Schlossman; C Morimoto
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  19 in total

1.  Fyn and Lck tyrosine kinases regulate tyrosine phosphorylation of p105CasL, a member of the p130Cas docking protein family, in T-cell receptor-mediated signalling.

Authors:  H Kanda; T Mimura; K Hamasaki; K Yamamoto; Y Yazaki; H Hirai; Y Nojima
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

Review 2.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

3.  Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.

Authors:  Qing Li; Xuedong Ding; Jeremy J Thomas; Clifford V Harding; Nicole D Pecora; Assem G Ziady; Samuel Shank; W Henry Boom; Christina L Lancioni; Roxana E Rojas
Journal:  J Leukoc Biol       Date:  2011-12-07       Impact factor: 4.962

4.  Adhesion to fibronectin promotes the activation of the p125(FAK)/Zap-70complex in human T cells.

Authors:  A Bearz; G Tell; S Formisano; S Merluzzi; A Colombatti; C Pucillo
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 5.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

6.  Enhancement of activation-induced cell death by fibronectin in murine CD4+ CD8+ thymocytes.

Authors:  E Takayama; T Kina; Y Katsura; T Tadakuma
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 7.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

8.  Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype.

Authors:  S L Pender; M T Salmela; G Monteleone; D Schnapp; C McKenzie; J Spencer; S Fong; U Saarialho-Kere; T T MacDonald
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 9.  Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement.

Authors:  Nicole M Chapman; Jon C D Houtman
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

10.  SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility.

Authors:  Hongyan Wang; Bin Wei; Georges Bismuth; Christopher E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.